Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin (Q42506818)

1 November 2017

title

Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin (English)

1 reference

1 November 2017

main subject

phase II clinical trial

0 references

author name string

Rodríguez-Cuevas S

1

1 reference

1 November 2017

Barroso-Bravo S

2

1 reference

1 November 2017

Almanza-Estrada J

3

1 reference

1 November 2017

Cristóbal-Martínez L

4

1 reference

1 November 2017

González-Rodríguez E

5

1 reference

1 November 2017

language of work or name

1 reference

1 July 2001

1 reference

Archives of Medical Research

1 November 2017

published in

1 reference

1 November 2017

volume

32

1 reference

1 November 2017

issue

4

1 reference

1 November 2017

page(s)

273-276

1 reference

Electric field-mediated fusion and related electrical phenomena

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Electrochemotherapy of spontaneous mammary tumours in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Identification of a plasma membrane protein that specifically binds bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Novel electrode designs for electrochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Electroporation therapy of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

A new brain tumour therapy combining bleomycin with in vivo electropermeabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

In vivo antitumor effects of electrochemotherapy in a hepatoma model

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Electrochemotherapy--a novel method of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

Antitumor electrochemotherapy: new advances in the clinical protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900278-8

7 January 2021

10.1016/S0188-4409(01)00278-8

Identifiers

DOI

1 reference

1 November 2017

1 reference